Deep phenotyping of Postural Orthostatic Tachycardia Syndrome

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to deeply phenotype Postural Orthostatic Tachycardia Syndrome (POTS) using various diagnostic modalities. The approach includes defining clinical classifications, assessing exercise tolerance through metabolomic evaluations, and identifying relevant biomarkers and clinical outcome measures. By utilizing blood work, autonomic function testing, skin biopsies, and patient surveys, the study seeks to enhance diagnostic accuracy and inform future treatment strategies for POTS patients. Additionally, a repository of blood biosamples will be established for future research.

Why it matters

Who can join: the full rules

Inclusion Criteria:

POTS Patients

* Age ≥ 14 years, able to provide informed consent (assent with parental consent for age \< 18) and comply with procedures
* Meets consensus criteria for POTS: (1) sustained increase in heart rate ≥ 30 bpm above supine baseline within 10 min of quiet standing or upright tilt (≥ 40 bpm in individuals 12 to 19 years of age) OR sustained upright HR (heart rate) \>120 bpm, (2) absence of orthostatic hypotension, (3) symptoms with standing that improve with sitting or lying down, (4) resting supine heart rate \< 100 bpm, (5) orthostatic symptoms present for at least 6 months
* Stable oral medication regimen for at least 14 days

Non-POTS Control Patients

* Healthy women, age 18 - 30 years, able to provide informed consent and comply with study procedures
* Does NOT meet consensus criteria for postural tachycardia syndrome
* No symptoms of orthostatic intolerance or dysautonomia. No history of other major medical disorder
* Resting supine heart rate \< 100 bpm

Exclusion Criteria:

None of the following exclusion criteria:

* Use of amphetamine-type stimulants, diuretics, selective norepinephrine reuptake inhibitor, anticholinergic medications (including tricyclic antidepressant medications), fludrocortisone, desmopressin in past 14 days
* Use of other autonomic drugs (adrenergic agents, pyridostigmine, droxidopa, triptans, ivabradine) in past 48 hours
* Currently receiving IVIG (Intravenous immunoglobulin), subcutaneous IgG (Immunoglobulin G), or any investigational medication (in past year)
* Infusion of iv fluids in past 7 days
* History or evidence of another condition explaining symptoms or orthostatic tachycardia (e.g. structural heart disease, CSF (Cerebrospinal fluid) hypovolemia, or severe traumatic brain injury)

Where it's running

• UT Southwestern Medical Center
  Dallas, Texas, United States Recruiting

Study contacts

• Principal investigator: Steven Vernino, MD PhD — University of Texas Southwestern Medical Center
• Study coordinator: Steve Hopkins
• Email: steve.hopkins@utsouthwestern.edu
• Phone: 214-648-9275

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• High salt diet for treating Postural Orthostatic Tachycardia Syndrome

  This study tests if a high salt diet can help people with Postural Orthostatic Tachycardia Syndrome feel better by improving their symptoms and blood volume.

  Recruiting University of Calgary · Calgary, Alberta · NCT05924646

• Testing IV saline for cognitive function in POTS and Long COVID patients

  This study is testing whether IV saline can help improve brain fog and mental fatigue in people with POTS and Long COVID.

  Recruiting University of Calgary · Calgary, Alberta · NCT05914649

• A study using wearable devices to manage Long COVID symptoms

  This study is testing if using wearable devices can help people with Long COVID manage their symptoms and improve their quality of life.

  Recruiting Scripps Translational Science Institute · La Jolla, California · NCT05741112

• Improving blood pressure control in children who faint

  This study is testing if certain movements can help children aged 6-18 who faint feel better by improving their blood pressure and heart function compared to regular advice.

  Recruiting Simon Fraser University · Burnaby, British Columbia · NCT05633693

• Assessing counterpressure maneuvers for preventing fainting in children

  This study is testing if teaching children techniques to prevent fainting can help them avoid losing consciousness when they visit the emergency room.

  Recruiting Simon Fraser University · Vancouver, British Columbia · NCT05555771

• Vagal nerve stimulation for treating symptoms in children with hypermobile Ehlers-Danlos Syndrome

  This study is testing two types of non-invasive vagal nerve stimulation therapies to see if they can help reduce gastrointestinal symptoms and improve the quality of life for children with hypermobile Ehlers-Danlos Syndrome.

  Recruiting Medical College of Wisconsin · Milwaukee, Wisconsin · NCT05212129

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.